Study to Evaluate the Efficacy of Adalimumab in Patients With Erosive Osteoarthritis of the Interphalangeal Finger Joints

Summary

Patients will be randomized into two groups (1/1) during one year: * 40 mg adalimumab subcutaneously (sc) every other week * placebo The effect on x-rays and clinical parameters will be evaluated.

Timeline

Start

2006-05

Primary completion

2009-01

Completion

2009-02

Drugs

Indications